About Bennevolance Pharma
Bennevolance Pharma is a Healthcare company based in Ahmedabad (India) founded in 2000. It produces high-quality finished dosage form products for the pharmaceutical industry. It operates on a B2B model. Its Indian entity Bennevolance Pharma Private Limited reported revenue of ₹7.82 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Finished Dosage Forms. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Bennevolance Pharma, founded in 2000 in Ahmedabad, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and finished dosage forms. Produces high-quality finished dosage form products for the pharmaceutical industry. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Ahmedabad, India
- SectorsHealthcare
- Website bennevolance.com
- Legal Name Bennevolance Pharma Private Limited
- Date of Incorporation 24 May, 2004
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹7.82 Cr
FY 2025 · +16% YoY
- Net Profit₹5.2 Lakh
FY 2025 · 1% margin
- EBITDA₹13.5 Lakh
FY 2025 · 2% margin
Associated legal entities of Bennevolance Pharma
Bennevolance Pharma operates through Bennevolance Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bennevolance Pharma Private Limited CIN U24231GJ2004PTC044162 | Active | 24 May 2004 | Ahmedabad, Gujarat | ₹7.8 Cr | – | 2 | View details |
Board of directors of Bennevolance Pharma Private Limited (Bennevolance Pharma)
Bennevolance Pharma Private Limited is the primary company behind Bennevolance Pharma. The board of Bennevolance Pharma Private Limited currently have 2 directors; the longest-serving is Ratna Jaiswal, appointed in 2011. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ratna Jaiswal DIN 05110673 | Director | 18 Nov 2011 | 14 yrs 11 mo | Bennevolance Pharma Private Limited |
| Kamaljeet Bholanath Jaiswal DIN 02107360 | Additional Director | 26 Dec 2020 | 5 yrs 9 mo | Bennevolance Pharma Private Limited |
Financials of Bennevolance Pharma
Figures of Bennevolance Pharma Private Limited, the primary company behind Bennevolance Pharma, for FY 2025. Revenue was ₹7.82 Cr (+16% year on year). Net profit was ₹5.2 Lakh (1% margin). EBITDA was ₹13.5 Lakh (2% margin). Revenue has grown at a compounded annual rate of -18% over three years and +6% over five years.
- ₹7.82 CrRevenue · FY 2025 · +16% YoY
- ₹5.2 LakhNet profit · 1% margin
- ₹13.5 LakhEBITDA · 2% margin
- ₹1 LakhPaid-up capital
- -18%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bennevolance Pharma Private Limited are on its company page.
Detailed financial statements for Bennevolance Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Bennevolance Pharma
Bennevolance Pharma has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Bennevolance Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Bennevolance Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bennevolance Pharma
Bennevolance Pharma was founded in 2000.
Bennevolance Pharma is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
The primary company behind Bennevolance Pharma, Bennevolance Pharma Private Limited, reported revenue of ₹7.82 Cr for FY 2025, up 16% year on year.
Bennevolance Pharma, founded in 2000 in Ahmedabad, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and finished dosage forms. Produces high-quality finished dosage form products for the pharmaceutical industry. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Bennevolance Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Bennevolance Pharma operates through Bennevolance Pharma Private Limited.
The legal entities of Bennevolance Pharma currently have 2 directors, including Kamaljeet Bholanath Jaiswal, Ratna Jaiswal.